4 Einträge von 9 mit bayer therapy
www.cslbehring.ch
Datum der Indexierung 13.03.2021 22:45:38
erkannte Namen Alex Gertsch | Gérard Jenni | Georg Ptak | Patricia Stutz | Corona Ladensterben |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords haemophilia from | phase japan | specialty market | study rviii | with immunoglobulins | patients clinical | products prophylaxis | bleeding breakthrough | rix-fp development | global medicines |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Bayer CSL627 rVIII-SingleChain Single chain BDD FVIII Submitted CSL Behring Alprolix FIX fused to Fc Market Biogen Idec 3 fold CSL654 rIX-FP FIX fused to albumin with cleavable linker Submitted CSL Behring 5 fold GlycoPEGylated rFIX FIX N-linked pegy therapy → 50-75% CR ~70% will relapse • CSL362 MOA – targets CD123 overexpressed on leukaemic cells o engineered to recruit immune killer cells o inhibits IL-3 activity Breakthrough Medicines 23 CSL362 – Acute Myeloid Leukaemia •
Text Inhalt Text aus URL
Log Metriken 446196
erkannte Namen Alex Gertsch | Gérard Jenni | Georg Ptak | Patricia Stutz | Corona Ladensterben |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords haemophilia from | phase japan | specialty market | study rviii | with immunoglobulins | patients clinical | products prophylaxis | bleeding breakthrough | rix-fp development | global medicines |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Bayer CSL627 rVIII-SingleChain Single chain BDD FVIII Submitted CSL Behring Alprolix FIX fused to Fc Market Biogen Idec 3 fold CSL654 rIX-FP FIX fused to albumin with cleavable linker Submitted CSL Behring 5 fold GlycoPEGylated rFIX FIX N-linked pegy therapy → 50-75% CR ~70% will relapse • CSL362 MOA – targets CD123 overexpressed on leukaemic cells o engineered to recruit immune killer cells o inhibits IL-3 activity Breakthrough Medicines 23 CSL362 – Acute Myeloid Leukaemia •
Text Inhalt Text aus URL
Log Metriken 446196
www.multiplesklerose-seeland.ch
Datum der Indexierung 29.03.2021 19:38:25
erkannte Namen Irène Arni | Ursula Biland | Marco Kaufmann | Georges Stooss | Claudio Gobbi | Lucienne Stooss | Jürg Kesselring | Marcel Grütter | Tosca Grütter | Walter Bessire |
weitere Namen in www.multiplesklerose-seeland.ch 27
Subdomain:
extern (outbound) Link/Domain 0 in www.multiplesklerose-seeland.ch
intern (inbound) Link/Domain www.multiplesklerose-seeland.ch
Alle Links in alle Links in www.multiplesklerose-seeland.ch
HTML Description pdf
Kombination Keywords physiotherapy symptoms | doi.org persons | with barriers | multiple model | sclerosis swiss | access variables | switzerland data | were health | analysis related | that study |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Bayer Schweiz AG, Teva, Merck, Sanofi Genzyme, Roche, Eli Lilly, Celgene and the Swiss MS Society (SMSG). CG The Department of Neurology, Regional Hospital Lugano (EOC), Lugano, Switzerland, receives financial support from Teva, Merck Serono, Biogen, therapy use and access-barriers in persons with multiple sclerosis: a cross-sectional analysis Multiple Sclerosis and Related Disorders 48 (2021) 102710 Available online 23 December 2020 2211-0348/© 2020 The Author(s). Published b
Text Inhalt Text aus URL
Log Metriken 473243
erkannte Namen Irène Arni | Ursula Biland | Marco Kaufmann | Georges Stooss | Claudio Gobbi | Lucienne Stooss | Jürg Kesselring | Marcel Grütter | Tosca Grütter | Walter Bessire |
weitere Namen in www.multiplesklerose-seeland.ch 27
Subdomain:
extern (outbound) Link/Domain 0 in www.multiplesklerose-seeland.ch
intern (inbound) Link/Domain www.multiplesklerose-seeland.ch
Alle Links in alle Links in www.multiplesklerose-seeland.ch
HTML Description pdf
Kombination Keywords physiotherapy symptoms | doi.org persons | with barriers | multiple model | sclerosis swiss | access variables | switzerland data | were health | analysis related | that study |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Bayer Schweiz AG, Teva, Merck, Sanofi Genzyme, Roche, Eli Lilly, Celgene and the Swiss MS Society (SMSG). CG The Department of Neurology, Regional Hospital Lugano (EOC), Lugano, Switzerland, receives financial support from Teva, Merck Serono, Biogen, therapy use and access-barriers in persons with multiple sclerosis: a cross-sectional analysis Multiple Sclerosis and Related Disorders 48 (2021) 102710 Available online 23 December 2020 2211-0348/© 2020 The Author(s). Published b
Text Inhalt Text aus URL
Log Metriken 473243
www.cslbehring.ch
Datum der Indexierung 05.05.2021 16:44:47
erkannte Namen Alex Gertsch | Gérard Jenni | Georg Ptak | Patricia Stutz | Corona Ladensterben |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf?la=fr-fr&hash=6A9CD360662B6CDEDCAE1B016E11BD8F68ED4E2B
Kombination Keywords haemophilia program | phase market | specialty rviii | study immunoglobulins | products prophylaxis | patients research | with breakthrough | global medicines | development rix-fp | clinical bleeding |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Bayer CSL627 rVIII-SingleChain Single chain BDD FVIII Submitted CSL Behring Alprolix FIX fused to Fc Market Biogen Idec 3 fold CSL654 rIX-FP FIX fused to albumin with cleavable linker Submitted CSL Behring 5 fold GlycoPEGylated rFIX FIX N-linked pegy therapy → 50-75% CR ~70% will relapse • CSL362 MOA – targets CD123 overexpressed on leukaemic cells o engineered to recruit immune killer cells o inhibits IL-3 activity Breakthrough Medicines 23 CSL362 – Acute Myeloid Leukaemia •
Text Inhalt Text aus URL
Log Metriken 446196
erkannte Namen Alex Gertsch | Gérard Jenni | Georg Ptak | Patricia Stutz | Corona Ladensterben |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf?la=fr-fr&hash=6A9CD360662B6CDEDCAE1B016E11BD8F68ED4E2B
Kombination Keywords haemophilia program | phase market | specialty rviii | study immunoglobulins | products prophylaxis | patients research | with breakthrough | global medicines | development rix-fp | clinical bleeding |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Bayer CSL627 rVIII-SingleChain Single chain BDD FVIII Submitted CSL Behring Alprolix FIX fused to Fc Market Biogen Idec 3 fold CSL654 rIX-FP FIX fused to albumin with cleavable linker Submitted CSL Behring 5 fold GlycoPEGylated rFIX FIX N-linked pegy therapy → 50-75% CR ~70% will relapse • CSL362 MOA – targets CD123 overexpressed on leukaemic cells o engineered to recruit immune killer cells o inhibits IL-3 activity Breakthrough Medicines 23 CSL362 – Acute Myeloid Leukaemia •
Text Inhalt Text aus URL
Log Metriken 446196
www.multiplesklerose-seeland.ch
Datum der Indexierung 13.03.2021 10:46:37
erkannte Namen Irène Arni | Ursula Biland | Alice Keiser | Bernhard Umhang | Anna Brunner | Helene Adam | Irma Löffel | Marco Kaufmann | Georges Stooss | Claudio Gobbi |
weitere Namen in www.multiplesklerose-seeland.ch 30
Subdomain:
extern (outbound) Link/Domain 0 in www.multiplesklerose-seeland.ch
intern (inbound) Link/Domain www.multiplesklerose-seeland.ch
Alle Links in alle Links in www.multiplesklerose-seeland.ch
HTML Description pdf
Kombination Keywords physiotherapy disease | with from | multiple symptoms | sclerosis model | switzerland data | were related | that swiss | study analysis | doi.org variables | health access |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Bayer Schweiz AG, Teva, Merck, Sanofi Genzyme, Roche, Eli Lilly, Celgene and the Swiss MS Society (SMSG). CG The Department of Neurology, Regional Hospital Lugano (EOC), Lugano, Switzerland, receives financial support from Teva, Merck Serono, Biogen, therapy use and access-barriers in persons with multiple sclerosis: A cross-sectional analysis Remo Fortunato a,j , Nico Arie van der Maas b , Ursula Biland-Thommen c , Marco Kaufmann a , Chlo´ e Sieber a , Christian P Kamm d,e ,
Text Inhalt Text aus URL
Log Metriken 473243
erkannte Namen Irène Arni | Ursula Biland | Alice Keiser | Bernhard Umhang | Anna Brunner | Helene Adam | Irma Löffel | Marco Kaufmann | Georges Stooss | Claudio Gobbi |
weitere Namen in www.multiplesklerose-seeland.ch 30
Subdomain:
extern (outbound) Link/Domain 0 in www.multiplesklerose-seeland.ch
intern (inbound) Link/Domain www.multiplesklerose-seeland.ch
Alle Links in alle Links in www.multiplesklerose-seeland.ch
HTML Description pdf
Kombination Keywords physiotherapy disease | with from | multiple symptoms | sclerosis model | switzerland data | were related | that swiss | study analysis | doi.org variables | health access |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Bayer Schweiz AG, Teva, Merck, Sanofi Genzyme, Roche, Eli Lilly, Celgene and the Swiss MS Society (SMSG). CG The Department of Neurology, Regional Hospital Lugano (EOC), Lugano, Switzerland, receives financial support from Teva, Merck Serono, Biogen, therapy use and access-barriers in persons with multiple sclerosis: A cross-sectional analysis Remo Fortunato a,j , Nico Arie van der Maas b , Ursula Biland-Thommen c , Marco Kaufmann a , Chlo´ e Sieber a , Christian P Kamm d,e ,
Text Inhalt Text aus URL
Log Metriken 473243